ENTA – Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc.ENTA
$5.23Name : Enanta Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $111,568,976.00
EPSttm : -4.95
Enanta Pharmaceuticals, Inc.
$5.23
5.77%$0.32Float Short %
14.92
Margin Of Safety %
Put/Call OI Ratio
0.21
EPS Next Q Diff
-0.21
EPS Last/This Y
1.06
EPS This/Next Y
-0.11
Price
5.23
Target Price
15.17
Analyst Recom
2.17
Performance Q
-6.44
Relative Volume
0.56
Beta
0.76
Ticker: ENTA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | ENTA | 4.93 | 0.36 | 0.12 | 954 |
| 2025-04-15 | ENTA | 5.16 | 0.34 | 3.00 | 1042 |
| 2025-04-16 | ENTA | 4.94 | 0.34 | 1.20 | 1042 |
| 2025-04-17 | ENTA | 5.13 | 0.33 | 0.00 | 1032 |
| 2025-04-18 | ENTA | 5.1 | 0.33 | 0.00 | 1032 |
| 2025-04-21 | ENTA | 5.24 | 0.20 | 0.00 | 800 |
| 2025-04-22 | ENTA | 5.5 | 0.20 | 0.00 | 800 |
| 2025-04-23 | ENTA | 5.61 | 0.19 | 0.00 | 829 |
| 2025-04-24 | ENTA | 5.66 | 0.19 | 53.00 | 842 |
| 2025-04-25 | ENTA | 5.58 | 0.26375176304654 | 8 | 896 |
| 2025-04-28 | ENTA | 5.63 | 0.26375176304654 | 8 | 896 |
| 2025-04-29 | ENTA | 5.78 | 0.29 | 0.00 | 912 |
| 2025-04-30 | ENTA | 6.09 | 0.29 | 0.00 | 911 |
| 2025-05-01 | ENTA | 6.04 | 0.28 | 0.00 | 920 |
| 2025-05-02 | ENTA | 5.95 | 0.27 | 0.00 | 947 |
| 2025-05-05 | ENTA | 5.45 | 0.27 | 0.00 | 948 |
| 2025-05-06 | ENTA | 5.05 | 0.28 | 0.00 | 954 |
| 2025-05-07 | ENTA | 5.06 | 0.20 | 1.00 | 1257 |
| 2025-05-08 | ENTA | 5.3 | 0.20 | 999.99 | 1266 |
| 2025-05-09 | ENTA | 5.27 | 0.21 | 0.00 | 1276 |
| 2025-05-12 | ENTA | 5.56 | 0.21 | 0.00 | 1276 |
| 2025-05-13 | ENTA | 5.23 | 0.21 | 0.00 | 1276 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | ENTA | 4.93 | 22.7 | - | -4.42 |
| 2025-04-15 | ENTA | 5.15 | 22.7 | - | -4.42 |
| 2025-04-16 | ENTA | 4.92 | 22.7 | - | -4.42 |
| 2025-04-17 | ENTA | 5.10 | 22.7 | - | -4.42 |
| 2025-04-18 | ENTA | 5.10 | 22.7 | - | -4.42 |
| 2025-04-21 | ENTA | 5.23 | 22.7 | - | -4.42 |
| 2025-04-22 | ENTA | 5.50 | 22.7 | - | -4.42 |
| 2025-04-23 | ENTA | 5.60 | 22.7 | - | -4.42 |
| 2025-04-24 | ENTA | 5.66 | 22.7 | - | -4.42 |
| 2025-04-25 | ENTA | 5.58 | 22.7 | - | -4.42 |
| 2025-04-28 | ENTA | 5.63 | 22.7 | - | -4.42 |
| 2025-04-29 | ENTA | 5.79 | 22.7 | - | -4.42 |
| 2025-04-30 | ENTA | 6.09 | 22.7 | - | -4.42 |
| 2025-05-01 | ENTA | 6.04 | 22.7 | - | -4.42 |
| 2025-05-02 | ENTA | 5.95 | 22.7 | - | -4.42 |
| 2025-05-05 | ENTA | 5.44 | 22.7 | - | -4.42 |
| 2025-05-06 | ENTA | 5.06 | 22.7 | - | -4.42 |
| 2025-05-07 | ENTA | 5.06 | 22.7 | - | -4.42 |
| 2025-05-08 | ENTA | 5.31 | 22.7 | - | -4.42 |
| 2025-05-09 | ENTA | 5.27 | 22.7 | - | -4.42 |
| 2025-05-12 | ENTA | 5.55 | 22.7 | - | -4.42 |
| 2025-05-13 | ENTA | 5.23 | 22.7 | - | -4.42 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-15 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-16 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-17 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-18 | ENTA | 1.97 | -6.11 | 13.46 |
| 2025-04-21 | ENTA | 1.97 | -6.89 | 13.46 |
| 2025-04-22 | ENTA | 1.97 | -6.89 | 13.46 |
| 2025-04-23 | ENTA | 1.97 | -6.89 | 13.46 |
| 2025-04-24 | ENTA | 1.97 | -6.89 | 13.46 |
| 2025-04-25 | ENTA | 1.97 | -6.89 | 13.46 |
| 2025-04-28 | ENTA | 1.97 | -9.90 | 14.15 |
| 2025-04-29 | ENTA | 1.97 | -9.90 | 14.15 |
| 2025-04-30 | ENTA | 1.97 | -9.90 | 14.15 |
| 2025-05-01 | ENTA | 1.97 | -9.90 | 14.15 |
| 2025-05-02 | ENTA | 1.97 | -9.90 | 14.15 |
| 2025-05-05 | ENTA | 1.97 | -10.59 | 14.15 |
| 2025-05-06 | ENTA | 1.97 | -10.59 | 14.15 |
| 2025-05-07 | ENTA | 1.97 | -10.59 | 14.15 |
| 2025-05-08 | ENTA | 1.97 | -10.59 | 14.15 |
| 2025-05-09 | ENTA | 1.97 | -10.59 | 14.15 |
| 2025-05-12 | ENTA | 1.97 | -8.62 | 14.92 |
| 2025-05-13 | ENTA | 1.97 | -8.62 | 14.92 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.05
Avg. EPS Est. Current Quarter
-1.14
Avg. EPS Est. Next Quarter
-1.26
Insider Transactions
1.97
Institutional Transactions
-8.62
Beta
0.76
Average Sales Estimate Current Quarter
15
Average Sales Estimate Next Quarter
15
Fair Value
Quality Score
25
Growth Score
27
Sentiment Score
85
Actual DrawDown %
94.9
Max Drawdown 5-Year %
-95.6
Target Price
15.17
P/E
Forward P/E
PEG
P/S
1.73
P/B
1
P/Free Cash Flow
EPS
-4.54
Average EPS Est. Cur. Y
-4.42
EPS Next Y. (Est.)
-4.53
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-149.57
Relative Volume
0.56
Return on Equity vs Sector %
-117.5
Return on Equity vs Industry %
-100.6
EPS 1 7Days Diff
EPS 1 30Days Diff
0.78
EBIT Estimation
Enanta Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 131
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
stock quote shares ENTA – Enanta Pharmaceuticals Inc Stock Price stock today
news today ENTA – Enanta Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ENTA – Enanta Pharmaceuticals Inc yahoo finance google finance
stock history ENTA – Enanta Pharmaceuticals Inc invest stock market
stock prices ENTA premarket after hours
ticker ENTA fair value insiders trading